Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Eczematous

Explore clinical trials studying Skin Diseases, Eczematous. Study availability and eligibility vary by location and protocol.

1,455 public trials 170 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Eczematous trial results

Completed

A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)

NCT02564055

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • GSK Investigational Site Fort Smith, Arkansas, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Irvine, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 60 locations
View Trial Details
Completed

Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT02260986

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Phoenix, Arizona, United States
  • Hot Springs, Arkansas, United States
  • Little Rock, Arkansas, United States
  • Encinitas, California, United States
View all 148 locations
View Trial Details
Completed

Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)

NCT01639040

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Berlin, Germany
  • Dresden, Germany
  • Dülmen, Germany
  • Frankfurt, Germany
View all 13 locations
View Trial Details
Completed

First in Human of Single and Multiple Doses of MOR106

NCT02739009

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • SGS LSS Clinical Pharmacology Unit Antwerp, Belgium
  • St Johns Hospital Budapest, Hungary
  • • Arensia Phase I unit Chisinau, Moldova
  • Arensia Phase I unit Bucharest, Romania
View Trial Details
Completed

A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis

NCT02340234

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Dermatology Research Associate Los Angeles, California, United States
  • UCSD Division of Dermatology San Diego, California, United States
  • Univ of Calif-San Francisco San Francisco, California, United States
  • University of Colorado; Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 74 locations
View Trial Details

Related conditions